Design, synthesis, and biological evaluation of novel PI3Kδ/HDAC6 dual inhibitors for the treatment of non-Hodgkin's lymphoma.

Eur J Med Chem

Institute of Basic and Translational Medicine, Xi'an Medical University, No.1 Xinwang Road, Xi'an 710021, Shaanxi Province, China. Electronic address:

Published: October 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

PI3Kδ and HDAC6 inhibitors play important roles in the treatment of lymphoma. Herein, a novel series of purine-based PI3Kδ/HDAC6 dual inhibitors have been rationally designed and synthesized by incorporating an HDAC pharmacophore into our previously reported PI3Kδ inhibitor scaffold. Structure-activity relationship (SAR) studies led to the discovery of the lead compound 22E, which showed potent inhibitory activity towards PI3Kδ and HDAC6, with IC values of 2.4 nM and 6.2 nM, respectively. Compound 22E showed significantly enhanced antiproliferative activities against multiple non-Hodgkin's lymphoma (NHL) cells compared with either selective PI3Kδ inhibitor or HDAC6 inhibitor, with IC values of 34 nM and 53 nM against SU-DHL-6 and JEKO-1 cells, respectively. Subsequent mechanistic studies revealed that compound 22E effectively arrested the cell cycle in the G0/G1 phase and induced cell apoptosis in SU-DHL-6 and JEKO-1 cells. Meanwhile, 22E could simultaneously block the PI3K/AKT/mTOR signaling pathway as well as increase the acetylation of α-tubulin and histone H3 levels. In addition, 22E prevented tumor growth in both SU-DHL-6 and JEKO-1 xenograft models, and there was no observable toxicity. These results demonstrated that 22E is a promising lead candidate with novel antitumor mechanism for the treatment of NHL.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2025.117852DOI Listing

Publication Analysis

Top Keywords

compound 22e
12
pi3kδ/hdac6 dual
8
dual inhibitors
8
non-hodgkin's lymphoma
8
pi3kδ hdac6
8
pi3kδ inhibitor
8
su-dhl-6 jeko-1 cells
8
22e
6
design synthesis
4
synthesis biological
4

Similar Publications

A new sesquiterpene from the leaves of Dryand with nitric oxide inhibitory activity.

Nat Prod Res

July 2025

Guangxi Key Laboratory of Green Chemical Materials and Safety Technology, Guangxi Engineering Research Center for Chemical New Materials and Safety Technology, College of Petroleum and Chemical Engineering, Beibu Gulf University, Qinzhou, China.

An undescribed sesquiterpene beibuxsocapsa A (), together with six known compounds, ergosterol (), 22,24-ergosta-7,22-diene-3,5α,6-triol (), stigmasterol (), stigmast-4-en-3-one (), stigmast-4-en-6-ol-3-one (), and loliolide () were successfully obtained from the CHCl (dichloromethane) extract prepared from the leaves of the Chinese mangrove plant, Dryand (Malvaceae). Their structures were unambiguously elucidated thorough spectroscopic examinations corroborated by comparisons with pertinent literature. The absolute configuration of compound was precisely determined through single-crystal X-ray diffraction of its modified structure.

View Article and Find Full Text PDF

Design, synthesis, and biological evaluation of novel PI3Kδ/HDAC6 dual inhibitors for the treatment of non-Hodgkin's lymphoma.

Eur J Med Chem

October 2025

Institute of Basic and Translational Medicine, Xi'an Medical University, No.1 Xinwang Road, Xi'an 710021, Shaanxi Province, China. Electronic address:

PI3Kδ and HDAC6 inhibitors play important roles in the treatment of lymphoma. Herein, a novel series of purine-based PI3Kδ/HDAC6 dual inhibitors have been rationally designed and synthesized by incorporating an HDAC pharmacophore into our previously reported PI3Kδ inhibitor scaffold. Structure-activity relationship (SAR) studies led to the discovery of the lead compound 22E, which showed potent inhibitory activity towards PI3Kδ and HDAC6, with IC values of 2.

View Article and Find Full Text PDF

The azo dye methyl 2-{2-[(E)-2-oxo-1,2-dihydronaphthalen-1-ylidene]hydrazin-1-yl}benzoate, CHNO, was synthesized and subjected to an extensive experimental and theoretical study. Crystallizing in the monoclinic space group P2/c, the compound was analyzed using X-ray diffraction and density functional theory (DFT) calculations with the B3LYP functional and 6-311G(d,p) basis set. The results demonstrated a strong correlation between the experimental and theoretical geometrical parameters, with one of the tautomeric forms (denoted K, the NH/C=O tautomer) showing greater stability.

View Article and Find Full Text PDF

Background: A direct synthesis of functionalized dimethyl fumarate derivatives of 2- (2-((E)-(2-oxoindolin-3-ylidene)methyl)-1H-benzo[d]imidazol-1-yl) is achieved via one-pot reaction involving 2-methyl-1H-benzo[d]imidazole and appropriate isatin in the presence of DMAD.

Methods: Conversely, this one-pot reaction furnished, upon conduction at 60 ° C, the 2-(2-((E)- (2-oxoindolin-3-ylidene)methyl)-1H-benzo[d]imidazol-1-yl) products. The biological activities were evaluated against JNK3 kinase.

View Article and Find Full Text PDF

Penicinoid A (), a previously undescribed sesterterpenoid, and ten known compounds, variculanol (), citreoanthrasteroid A (), ergosta-7,22-diene-2,3,9-triol (), (22,24)-23-methylergosta-7,22-diene-3,5,6,9-tetrol (), 9,11-dehydroergosterol peroxide (), (22,24)-3,5,9-trihydroxy-ergosta-7,22-dien-6-one (), gymnasterone C (), cyathisterol (), demethylincisterol A3 (), volemolide (), were obtained from endophytic fungus . Their structures were characterised by NMR, HRESIMS, ECD calculations and comparison with the reported literatures. All isolates were screened on their cytotoxicity against A549, Hepg2, HeLa, and HCT116 cells.

View Article and Find Full Text PDF